Literature DB >> 12646123

Serum IgE level in malnutrition.

W C N Forte1, M C Santos de Menezes, C Horta, R Carneiro Leão Bach.   

Abstract

UNLABELLED: Infections and malnutrition remain the main causes of infant mortality in developing countries. In protein-calorie malnutrition, immunologic responses are affected, which often facilitates infections. However, the presence of asthma and allergic rhinitis are not commonly recognized in malnourished individuals. The aim of this study was to evaluate serum IgE values in children with primary moderate protein-calorie malnutrition.
METHODS: The level of IgE in peripheral blood of 18 children between 2 and 4 old with moderate protein-calorie malnutrition and without associated parasitic infestation was compared with that of 15 well nourished children of similar age. IgE serum levels were measured by an immunoenzymatic method.
RESULTS: The median level of serum IgE in malnourished children was 69.30 ng/ml while the control group showed a mean level of 95.97 ng/ml. This difference was significant (p < 0.01).
CONCLUSION: Malnourished children show decreased serum IgE levels. This might be one of the adaptive mechanisms of malnutrition employed in an attempt to use energy and protein reserves for growth and other functions. Our results are coherent with the decrease in IgE mediated reactions in malnourished patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12646123     DOI: 10.1016/s0301-0546(03)79173-3

Source DB:  PubMed          Journal:  Allergol Immunopathol (Madr)        ISSN: 0301-0546            Impact factor:   1.667


  2 in total

1.  Macronutrient deprivation modulates antigen trafficking and immune recognition through HSC70 accessibility.

Authors:  Sarah N Deffit; Janice S Blum
Journal:  J Immunol       Date:  2015-01-14       Impact factor: 5.422

Review 2.  The immune system in children with malnutrition--a systematic review.

Authors:  Maren Johanne Heilskov Rytter; Lilian Kolte; André Briend; Henrik Friis; Vibeke Brix Christensen
Journal:  PLoS One       Date:  2014-08-25       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.